Mighty morphed brain cells cure Parkinson’s in mice, but human trials still far off – STAT
STAT |
Mighty morphed brain cells cure Parkinson’s in mice, but human trials still far off
STAT Instead, several labs have therefore used stem cells to produce dopamine neurons in dishes. Transplanted 4 into the brains of lab rats with Parkinson’s, the neurons reduced rigidity, tremor, and other symptoms. Human studies are expected to begin in … Cell Therapy 2.0: Reprogramming the Brain’s Own Cells for Parkinson’s TreatmentScientific American Brain cells reprogrammed to make dopamine, with goal of Parkinson’s therapyThe San Diego Union-Tribune Brain cell transplants could help treat Parkinson’s diseaseMedical Xpress The Scientist all 31 news articles » |
STAT |
Mighty morphed brain cells cure Parkinson’s in mice, but human trials still far off
STAT Instead, several labs have therefore used stem cells to produce dopamine neurons in dishes. Transplanted 4 into the brains of lab rats with Parkinson’s, the neurons reduced rigidity, tremor, and other symptoms. Human studies are expected to begin in … Cell Therapy 2.0: Reprogramming the Brain’s Own Cells for Parkinson’s TreatmentScientific American Brain cells reprogrammed to make dopamine, with goal of Parkinson’s therapyThe San Diego Union-Tribune Brain cell transplants could help treat Parkinson’s diseaseMedical Xpress The Scientist all 31 news articles » |
The San Diego Union-Tribune |
Brain cells reprogrammed to make dopamine, with goal of Parkinson’s therapy
The San Diego Union-Tribune The study is a more sophisticated version of gene therapy approaches that have previously been investigated for Parkinson’s, and is worth pursuing, said Parkinson’s disease researcher Andres Bratt-Leal. However, much more work needs to be done before … |
Medical Xpress |
Time-lapse video reveals cells essential for ‘birth’ of blood stem cells
Medical Xpress St. Jude researchers used time-lapse images to investigate the origins of blood stem cells in models like the example above. The image was fluoresced in order to help identify the cells involved. Credit: Erich Damm / St, Jude Children’s Research Hospital. |
|
Do We Need Biomarkers to Predict Tumor Hyper-Progression Following Immunotherapy?
AJMC.com Managed Markets Network The study evaluated tumor biopsies of 155 stage IV cancer patients who had received immunotherapy treatments—inhibitors of CTLA-4, programmed death 1 (PD-1), programmed death ligand-1 (PD-L1), or other immunotherapy agents. Hyper-progression … |
|
CBMG and GE Healthcare Life Sciences China Partner on CAR T-Cell and Stem Cell Manufacturing
Genetic Engineering & Biotechnology News Cellular Biiomedicine Group and GE Healthcare Life Sciences China agreed to a strategic research collaboration to co-develop certain high-quality industrial control processes in Chimeric Antigen Receptor T–cell (CAR-T) and stem cell manufacturing. |